| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Alejandro Brun | Q43144723 |
| Hani Boshra | Q55456244 | ||
| P2093 | author name string | Núria Busquets | |
| Gema Lorenzo | |||
| P2860 | cites work | Animals as sentinels of bioterrorism agents | Q24623783 |
| The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection | Q27485926 | ||
| Single-particle cryo-electron microscopy of Rift Valley fever virus | Q27488344 | ||
| Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA | Q27491320 | ||
| Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation | Q27662293 | ||
| Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors | Q40237419 | ||
| Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep | Q40358602 | ||
| Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. | Q40365121 | ||
| Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus | Q40368584 | ||
| Rift valley fever virus L protein forms a biologically active oligomer | Q40377637 | ||
| A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity | Q40379142 | ||
| Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers | Q40397884 | ||
| Potential for North American mosquitoes to transmit Rift Valley fever virus | Q40398345 | ||
| Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus | Q40399200 | ||
| Rift Valley fever outbreak--Kenya, November 2006-January 2007. | Q40458723 | ||
| Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. | Q40473787 | ||
| Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus | Q40498246 | ||
| Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment | Q40499504 | ||
| Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. | Q40579610 | ||
| Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. | Q40632227 | ||
| Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle | Q40645625 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses | Q40752380 | ||
| Complete nucleotide sequence of the M RNA segment of Uukuniemi virus encoding the membrane glycoproteins G1 and G2. | Q40794024 | ||
| Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials | Q40805536 | ||
| A perspective on emerging mosquito and phlebotomine-borne diseases in Europe. | Q44151483 | ||
| Manifestations of severe Rift Valley fever in Sudan | Q46975916 | ||
| Rift Valley fever. | Q52655181 | ||
| Rift Valley fever virus | Q56503351 | ||
| Rift Valley fever, South Africa - update | Q84335380 | ||
| Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription | Q27664646 | ||
| TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
| A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. | Q33316823 | ||
| Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines | Q33570326 | ||
| Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus | Q33617793 | ||
| A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge | Q33621078 | ||
| Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. | Q33884060 | ||
| Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine | Q34431934 | ||
| Mechanism of tripartite RNA genome packaging in Rift Valley fever virus | Q34490520 | ||
| Rift Valley fever virus | Q34971963 | ||
| Rift Valley fever: an uninvited zoonosis in the Arabian peninsula | Q35077306 | ||
| Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. | Q35107614 | ||
| Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine | Q36131361 | ||
| NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
| Ribonucleoproteins of Uukuniemi virus are circular | Q36531460 | ||
| Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. | Q36797004 | ||
| Prediction of a Rift Valley fever outbreak | Q37061637 | ||
| Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs | Q37087027 | ||
| Pathological studies on postvaccinal reactions of Rift Valley fever in goats | Q37274070 | ||
| Circular forms of Uukuniemi virion RNA: an electron microscopic study | Q37503326 | ||
| Rift Valley fever--a threat for Europe? | Q37733822 | ||
| Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine | Q38915999 | ||
| Rift Valley Fever Virus: Some Ultrastructural Observations on Material from the Outbreak in Egypt 1977 | Q38991879 | ||
| NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
| Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants | Q39196376 | ||
| Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
| Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus | Q39653963 | ||
| Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein | Q39686341 | ||
| Entry of bunyaviruses into mammalian cells | Q39694035 | ||
| Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge | Q39754768 | ||
| Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. | Q39778891 | ||
| Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins | Q39779815 | ||
| The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules | Q39870549 | ||
| Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector | Q39877530 | ||
| Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. | Q39953693 | ||
| Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression | Q40129877 | ||
| Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins | Q40233812 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rift Valley fever | Q326638 |
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 6098-6105 | |
| P577 | publication date | 2011-03-30 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Rift valley fever: recent insights into pathogenesis and prevention | |
| P478 | volume | 85 |
| Q39063232 | A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt |
| Q37019225 | A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching |
| Q102369135 | A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge |
| Q28652584 | A novel panel of monoclonal antibodies against Schmallenberg virus nucleoprotein and glycoprotein Gc allows specific orthobunyavirus detection and reveals antigenic differences |
| Q37004283 | A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection |
| Q35027744 | A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. |
| Q59335452 | A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice |
| Q37547173 | Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets |
| Q37956499 | Animal models of Rift Valley fever virus infection |
| Q34448192 | Bunyavirus-vector interactions |
| Q56881173 | Bunyaviruses: from transmission by arthropods to virus entry into the mammalian host first-target cells |
| Q93165183 | Combinatorial Minigenome Systems for Emerging Banyangviruses Reveal Viral Reassortment Potential and Importance of a Protruding Nucleotide in Genome "Panhandle" for Promoter Activity and Reassortment |
| Q35438525 | Coupling Vector-host Dynamics with Weather Geography and Mitigation Measures to Model Rift Valley Fever in Africa. |
| Q35531617 | Creation of a nonspreading Rift Valley fever virus |
| Q33401906 | Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies |
| Q34281104 | Culex pipiens, an experimental efficient vector of West Nile and Rift Valley fever viruses in the Maghreb region. |
| Q40214312 | Development of a Rift Valley fever virus viremia challenge model in sheep and goats |
| Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
| Q40292321 | Efficacy of three candidate Rift Valley fever vaccines in sheep. |
| Q40170227 | Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination |
| Q40232418 | Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc. |
| Q37036679 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus |
| Q40259168 | Microfluidic platforms for RNA interference screening of virus-host interactions |
| Q92058575 | Nucleocapsid protein-specific IgM antibody responses in the disease progression of severe fever with thrombocytopenia syndrome |
| Q40049043 | Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q34687464 | Plant-based vaccines against viruses. |
| Q40068118 | Plant-made vaccines and reagents for the One Health initiative |
| Q31111619 | Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells |
| Q36574005 | Rift Valley fever and a new paradigm of research and development for zoonotic disease control |
| Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q40144467 | Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal. |
| Q37067311 | Seroprevalence of Rift Valley fever virus in sheep and goats in Zambézia, Mozambique |
| Q35804998 | Seroprevalence of Sheep and Goat Pox, Peste Des Petits Ruminants and Rift Valley Fever in Saudi Arabia |
| Q33405724 | Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines |
| Q34734608 | Systems to establish bunyavirus genome replication in the absence of transcription |
| Q64252092 | The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review |
| Q34634852 | The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses |
| Q38235888 | The role of the IKK complex in viral infections |
| Q36759758 | Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase |
| Q36542318 | Transmission Dynamics of Rift Valley Fever Virus: Effects of Live and Killed Vaccines on Epizootic Outbreaks and Enzootic Maintenance |
| Q40127677 | Tropical ophthalmology : Intraocular inflammation caused by "new" infectious pathogens and travel-related infections |
| Q47551287 | Understanding the legal trade of cattle and camels and the derived risk of Rift Valley Fever introduction into and transmission within Egypt. |
| Q38141385 | Vaccines against diseases transmitted from animals to humans: a one health paradigm |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q40254473 | Virus-like particle-based countermeasures against Rift Valley fever virus |
| Q26998819 | Viruses and antiviral immunity in Drosophila |
| Q59357518 | West Nile virus and other mosquito-borne viruses present in Eastern Europe |
Search more.